PAOG Announces New CBD Nutraceutical Targeting $a hundred Billion Sleep Aid Market
SANDUSKY, Ohio, Oct. 18, 2021 /PRNewswire/ — PAO Group, Inc. (USOTC: PAOG) introduced its first CBD nutraceutical product, RelaxRX CBD, asleep resource.
RelaxRX is available in 30mg Softgels and an 1800mg Tincture. The CBD oil is 100% derived from complete spectrum complete plant hemp oil and incorporates no delivered chemicals.
The sleep functional resource marketplace changed into projected at USD 64.29 Billion in 2019 and is forecast to hit USD one hundred and one.7 Billion in 2026.
PAOG has delivered its first CBD nutraceutical product to its distribution accomplice, North American Cannabis Holdings, Inc. (USOTC: USMJ). The product will soon be for sale online at www.USMJ.Com.
PAOG expects sales to grow hastily following its first CBD nutraceutical product launch. The agency has complied with products covered up to follow the first product, including ordinary income capability.
PAOG plans to announce its subsequent CBD nutraceutical later this week.
Last 12 months, PAOG obtained highbrow belongings derived through studies into CBD extracted associated with a patented extraction technique (U.S. Patent No. Nine,199,960). PAOG is growing both pharmaceutical and nutraceutical remedies based on these highbrow assets.
Learn more excellent approximately USMJ’s ecommerce site at www.Usmj.Com.
Learn more excellent approximately PAOG at www.Paogroupinc.Com.
Forward-Looking Statements: Certain statements in this information release may comprise forward-searching facts in the meaning of Rule a hundred seventy-five under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934 and are situated to the secure harbor created via the one’s rules. All statements, aside from statements of reality covered on this launch, together with, without hindrance, statements regarding the organization’s potential destiny plans and objectives, are ahead-looking statements that involve dangers and uncertainties. There can be no guarantee that such statements will prove correct and actual results and destiny events may want to vary materially from those predicted in such statements. Technical headaches, which may stand up, should prevent implementing any strategically tremendous plan(s) mentioned above. The Company undertakes no obligation to revise or update any forward-searching statements to reflect occasions or instances after the date of this release.